NASDAQ:CTIC - CTI BioPharma Corp.
$0.81
 $0.01
+0.63%
4:00PM EDT
2019-07-15
CTI BioPharma Corp. (CTI) is a biopharmaceutical company focused on the acquisition, development and commercialization of targeted therapies covering a spectrum of blood-related cancers to patients and healthcare providers. The Company is primarily focused on commercializing PIXUVRI in select countries in the European Union, for multiply relapsed or refractory aggressive B-cell non-Hodgkin lymphoma (NHL). It is also engaged in evaluating pacritinib for the treatment of adult patients with myelofibrosis. Its earlier stage product candidate, tosedostat, is an oral, once-daily aminopeptidase inhibitor that has demonstrated responses in patients with acute myeloid leukemia (AML). It also evaluates its pipeline candidate paclitaxel poliglumex (Opaxio), which targets solid tumors. It is evaluating Opaxio through cooperative group sponsored trials and investigator-sponsored trials (ISTs), such as the ongoing maintenance therapy trial in patients with ovarian cancer. Read more at  reuters.com
sector:  health care
industry:  biotechnology
the data below are updated and published after 9pm EDT each trading day
  CTIC     avg for
industry  
  avg for
sector  
42 stocks weight:  10. 27   114. 77   204. 78  
42 stocks rank:  3. 80 K 1. 44 K 810. 33  
# analyst opinions:  3. 00   13. 59   13. 86  
mean recommendation:  2. 00   2. 12   2. 04  

quick ratio:  3. 89   5. 48   1. 89  
current ratio:  4. 04   5. 85   2. 40  

target price low:  0. 53   82. 72   115. 11  
target price avg:  0. 80   104. 42   138. 02  
target price high:  1. 27   130. 64   159. 47  
1-yr high:  3. 99   110. 27   142. 72  
last close:  0. 80   85. 12   126. 54  
50-day avg:  0. 87   86. 06   122. 35  
200-day avg:  1. 21   88. 76   121. 75  
1-yr low:  0. 73   69. 26   100. 63  
volume:  149. 54 K 3. 51 M 5. 53 M
50-day avg volume:  294. 84 K 3. 21 M 4. 22 M
200-day avg volume:  299. 93 K 3. 04 M 4. 75 M

1-day return:  -1. 76 % -0. 30 % -1. 01 %
this week return:  -1. 77 % -2. 16 % -1. 35 %
12-wk return:  -17. 53 % 3. 34 % 8. 69 %
52-wk return:  -81. 25 % -1. 76 % 12. 22 %

enterprise value (EV):  -2. 27 M 46. 50 B 123. 99 B
market cap:  46. 07 M 40. 77 B 109. 11 B
EBITDA:  -37. 06 M 4. 33 B 8. 19 B
enterprise multiple (EV/EBITDA):  0. 06   5. 45   12. 05  
enterprise/revenue (EV/R):  -0. 14   50. 46   9. 50  
total revenue:  16. 08 M 10. 21 B 40. 60 B
total debt:  19. 12 M 11. 27 B 17. 58 B
debt/equity:  42. 87   57. 36   120. 25  
net income (common):  -36. 11 M 2. 13 B 4. 27 B

shares outstanding:  57. 98 M 551. 08 M 1. 24 B
shares:  35. 62 M 559. 41 M 1. 22 B
shares short:  2. 84 M 11. 15 M 11. 94 M
shares short prior month:  1. 96 M 9. 31 M 11. 96 M
short ratio:  6. 83   5. 72   3. 43  
short % of float:  5. 82 % 6. 40 % 2. 65 %
total cash/share:  1. 07   11. 00   9. 23  
total cash:  62. 25 M 6. 03 B 6. 01 B
free cash flow:  -26. 55 M 3. 02 B 4. 96 B
operating cash flow:  -40. 86 M 3. 92 B 5. 99 B

book value:  0. 87   13. 02   27. 49  
price/book:  0. 92   4. 21   8. 80  
gross profits:  25. 41 M 7. 67 B 36. 29 B
operating margins:  -234. 03 % -380. 20 % -38. 44 %
EBITDA margins:  -230. 41 % 13. 59 % 23. 24 %
profit margins:  -224. 53 % 10. 94 % 14. 00 %
gross margins:  94. 54 % 36. 11 % 55. 16 %

1-yr max volatility:  43. 03 % --- ---
1-yr mean volatility:  3. 02 % 1. 50 % 1. 08 %

1-yr EPS:  -0. 62   2. 12   4. 26  
forward EPS:  -1. 03   3. 47   7. 14  
P/E:  -1. 28   2. 15   33. 17  
forward P/E:  -0. 79   -4. 03   17. 60  
PE/G:  0. 01   0. 54   0. 34  
growth:  -94. 10 % 263. 03 % 78. 34 %
earnings high:  -0. 19   0. 91   1. 70  
earnings avg:  -0. 19   0. 71   1. 58  
earnings low:  -0. 19   0. 48   1. 46  
revenue high:  -0. 00   2. 64 B 11. 26 B
revenue avg:  -0. 00   2. 58 B 11. 09 B
revenue low:  -0. 00   2. 54 B 10. 90 B
return on assets:  -24. 57 % -2. 31 % 5. 31 %
return on equity:  -59. 41 % -82. 48 % 135. 30 %
revenue growth:  -94. 10 % 262. 60 % 72. 94 %
revenue/share:  0. 28   12. 77   61. 38  

beta (1yr vs S&P500):  2. 04   1. 26   0. 91  
sharpe (1yr):  -1. 50   0. 07   0. 77  

held % insiders:  0. 76 % 6. 08 % 3. 31 %
held % institutions:  61. 04 % 78. 36 % 69. 61 %

Research more with google or yahoo!
the data below are updated and re-published at 8pm EDT after each trading day

2019-07-14 : CTIC
.    100.931 =       100.931 :: --> INITIAL WEIGHT <--
.    - 0.623 =       100.308 :: earnings per-share addition
.                               --> FUNDAMENTALS <--
.    x 1.976 =       198.204 :: P/E factor
.    x 2.209 =       437.825 :: PE/G factor
.    x 1.534 =       671.625 :: beta factor
.    x 0.797 =       535.328 :: sharpe factor
.    x 2.691 =       1440.48 :: current ratio factor
.     x 1.16 =      1671.292 :: quick ratio factor
.    x 1.071 =      1789.463 :: short ratio factor
.    x 1.005 =      1797.691 :: price-to-book factor
.    x 4.559 =      8194.857 :: EBITDA factor
.    x 1.006 =      8240.616 :: EBITDA vs industry factor
.    x 0.942 =       7765.66 :: debt-to-revenue factor
.    x 1.322 =     10265.568 :: debt-to-equity factor
.                               --> PERFORMANCE <--
.    x 2.114 =     21701.252 :: sector+industry 1-year gains factor
.    x 1.033 =     22426.031 :: industry 12-weeks return factor
.    x 1.305 =     29272.108 :: industry 2-weeks return factor
.    / 2.013 =     14538.037 :: overall "drift" factor
.    x 0.894 =     13003.265 :: largest single-day jump factor
.    x 0.061 =        793.85 :: low price factor
.    x 0.431 =       342.303 :: notable returns + performance factor
.                               --> PROJECTIONS <--
.    x 0.991 =       339.097 :: forward EPS factor
.    x 0.997 =       337.943 :: forward P/E factor
.    x 1.182 =       399.601 :: industry recommendation factor
.    x 2.122 =        847.76 :: company recommendation factor
.    x 1.008 =       854.244 :: factor historical industry gain for week 28
.    x 0.912 =       778.925 :: target low factor
.      x 1.0 =       778.925 :: target mean factor
.    x 1.032 =       804.087 :: target high factor
.    x 9.948 =      7998.655 :: spline projection factor
.                               --> FINAL ADJUSTMENTS <--
.  quad root =         9.457 :: reduced for readability
.    + 0.809 =        10.266 :: add/subtract for investor sentiment
.                               --> FINAL WEIGHT <--
.                     10.266 :: FINAL WEIGHT for NASDAQ:CTIC


 


News feed RSS items generated from finance.google.com

News feed formatting by feed2js.org